Micronuclei in Kif18a mutant mice form stable micronuclear envelopes and do not promote tumorigenesis

Leslie A Sepaniac1, Whitney Martin2, Louise A Dionne2

  • 1Department of Molecular Physiology and Biophysics, University of Vermont, Burlington, VT.

The Journal of Cell Biology
|September 13, 2021
PubMed

Insights

Micronuclei, linked to cancer, can form stable nuclear envelopes in Kif18a mutant mice. Loss of Trp53 gene induced tumors, suggesting not all micronuclei drive tumorigenesis.

Area of Science:

  • Cell Biology
  • Genetics
  • Cancer Research

Background:

  • Micronuclei, indicative of genomic instability, are implicated as drivers of tumorigenesis.
  • Kif18a mutant mice paradoxically form micronuclei without developing spontaneous tumors.

Purpose of the Study:

  • To investigate the nature of micronuclei in Kif18a mutant mice.
  • To determine if Trp53 gene deletion influences tumor formation in Kif18a mutant mice with micronuclei.

Main Methods:

  • Analysis of micronuclei formation and stability in Kif18a mutant mice and KIF18A knockout cells.
  • Deletion of the Trp53 gene in Kif18a mutant mice.
  • Comparison of micronuclei characteristics induced by Kif18a deficiency versus nocodazole washout or radiation.

Main Results:

  • Micronuclei in Kif18a mutant mice form stable nuclear envelopes.
  • Trp53 gene deletion in Kif18a mutant mice led to thymic lymphoma with elevated micronuclei.
  • KIF18A knockout cells showed stable micronuclei with decondensing chromatin and nuclear envelope components.

Conclusions:

  • Micronuclei in Kif18a deficiency are distinct, forming stable nuclear envelopes.
  • The presence of stable micronuclei alone does not necessarily promote tumorigenesis.
  • Tumorigenesis associated with micronuclei may depend on additional genetic factors like Trp53.